Insights Into the Role of Tick Salivary Protease Inhibitors During Ectoparasite–Host Crosstalk
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Downloaded from NCBI
bioRxiv preprint doi: https://doi.org/10.1101/818179; this version posted October 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Proteolysis and neurogenesis modulated by LNR domain proteins explosion 2 support male differentiation in the crustacean Oithona nana 3 Kevin Sugier1, Romuald Laso-Jadart1, Soheib Kerbache1, Jos Kafer4, Majda Arif1, Laurie Bertrand2, Karine 4 Labadie2, Nathalie Martins2, Celine Orvain2, Emmanuelle Petit2, Julie Poulain1, Patrick Wincker1, Jean-Louis 5 Jamet3, Adriana Alberti2 and Mohammed-Amin Madoui1 6 1. Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Univ Evry, Université 7 Paris-Saclay, Evry, France 8 2. Commissariat à l'Energie Atomique (CEA), Institut François Jacob, Genoscope, Evry, France 9 3. Université de Toulon, Aix-Marseille Université, CNRS/INSU/IRD, Mediterranean Institute of 10 Oceanography MIO UMR 7294, CS 60584, 83041 Toulon cedex 9, France 11 4. Laboratoire de Biométrie et Biologie Evolutive, Université Lyon 1, CNRS UMR 5558, France 12 bioRxiv preprint doi: https://doi.org/10.1101/818179; this version posted October 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 13 Abstract 14 Copepods are the most numerous animals and play an essential role in the marine trophic web 15 and biogeochemical cycles. The genus Oithona is described as having the highest numerical 16 density, as the most cosmopolite copepod and iteroparous. The Oithona male paradox obliges 17 it to alternate feeding (immobile) and mating (mobile) phases. -
Plant Protease Inhibitors: a Defense Strategy in Plants
Biotechnology and Molecular Biology Review Vol. 2 (3), pp. 068-085, August 2007 Available online at http://www.academicjournals.org/BMBR ISSN 1538-2273 © 2007 Academic Journals Standard Review Plant protease inhibitors: a defense strategy in plants Huma Habib and Khalid Majid Fazili* Department of Biotechnology, The University of Kashmir, P/O Naseembagh, Hazratbal, Srinagar -190006, Jammu and Kashmir, India. Accepted 7 July, 2007 Proteases, though essentially indispensable to the maintenance and survival of their host organisms, can be potentially damaging when overexpressed or present in higher concentrations, and their activities need to be correctly regulated. An important means of regulation involves modulation of their activities through interaction with substances, mostly proteins, called protease inhibitors. Some insects and many of the phytopathogenic microorganisms secrete extracellular enzymes and, in particular, enzymes causing proteolytic digestion of proteins, which play important roles in pathogenesis. Plants, however, have also developed mechanisms to fight these pathogenic organisms. One important line of defense that plants have to fight these pathogens is through various inhibitors that act against these proteolytic enzymes. These inhibitors are thus active in endogenous as well as exogenous defense systems. Protease inhibitors active against different mechanistic classes of proteases have been classified into different families on the basis of significant sequence similarities and structural relationships. Specific protease inhibitors are currently being overexpressed in certain transgenic plants to protect them against invaders. The current knowledge about plant protease inhibitors, their structure and their role in plant defense is briefly reviewed. Key words: Proteases, enzymes, protease inhibitors, serpins, cystatins, pathogens, defense. Table of content 1. -
Functional Characterization of Extracellular Protease Inhibitors of Phytophthora Infestans
FUNCTIONAL CHARACTERIZATION OF EXTRACELLULAR PROTEASE INHIBITORS OF PHYTOPHTHORA INFESTANS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Miaoying Tian, M.S. * * * * * The Ohio State University 2005 Dissertation Committee: Dr. Sophien Kamoun, Adviser Dr. Terrence L. Graham Approved by Dr. Saskia A. Hogenhout Dr. Margaret G. Redinbaugh Adviser Dr. Guo-Liang Wang Graduate Program in Plant Pathology ABSTRACT The oomycetes form one of several lineages within the eukaryotes that independently evolved a parasitic lifestyle and are thought to have developed unique mechanisms of pathogenicity. The devastating oomycete plant pathogen Phytophthora infestans causes late blight, a ravaging disease of potato and tomato. Little is known about processes associated with P. infestans pathogenesis, particularly the suppression of host defense responses. We used data mining of P. infestans sequence databases to identify 18 extracellular protease inhibitors belonging to two major structural classes: (i) Kazal-like serine protease inhibitors (EPI1 to EPI14) and (ii) cystatin-like cysteine protease inhibitors (EPIC1 to EPIC4). A variety of molecular, biochemical and bioinformatic approaches were employed to functionally characterize these genes and investigate their roles in pathogen virulence. The 14 EPI proteins form a diverse family and appear to have evolved by domain shuffling, gene duplication, and diversifying selection to target a diverse array of serine proteases. Recombinant EPI1 and EPI10 proteins inhibited subtilisin A among major serine proteases, and inhibited and interacted with tomato P69B subtilase, a pathogenesis-related protein belonging to PR7 class. The recombinant cystatin-like cysteine protease inhibitor EPIC2B interacted with a novel tomato papain-like extracellular cysteine protease PIP1 with an implicated role in plant defense. -
The Serpintine Solution
& Experim l e ca n i t in a l l C C f a Journal of Clinical & Experimental o r d l i a o n l o r g u Lucas et al., J Clin Exp Cardiolog 2017, 8:1 y o J Cardiology ISSN: 2155-9880 DOI: 10.4172/2155-9880.1000e150 Editorial Open Access The Serpintine Solution Alexandra Lucas, MD, FRCP(C)1,2,*, Sriram Ambadapadi, PhD1, Brian Mahon, PhD3, Kasinath Viswanathan, PhD4, Hao Chen, MD, PhD5, Liying Liu, MD6, Erbin Dai, MD6, Ganesh Munuswami-Ramanujam, PhD7, Jacek M. Kwiecien, DVM, MSc, PhD8, Jordan R Yaron, PhD1, Purushottam Shivaji Narute, BVSc & AH, MVSc, PhD1,9, Robert McKenna, PhD10, Shahar Keinan, PhD11, Westley Reeves, MD, PhD12, Mark Brantly, MD, PhD13, Carl Pepine, MD, FACC14 and Grant McFadden, PhD1 1Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe AZ, USA 2Saint Josephs Hospital, Dignity Health Phoenix, Phoenix, AZ, USA 3NIH/ NIDDK, Bethesda MD, USA 4Zydus Research Centre, Ahmedabad, India 5Department of tumor surgery, The Second Hospital of Lanzhou University, Lanzhou, Gansu, P.R.China 6Beth Israel Deaconess Medical Center, Harvard, Boston, MA, USA 7Interdisciplinary Institute of Indian system of Medicine (IIISM), SRM University, Chennai, Tamil Nadu, India 8MacMaster University, Hamilton, ON, Canada 9Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda MD, USA 10Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA 11Cloud Pharmaceuticals, Durham, North Carolina, USA 12Division of Rheumatology, University of Florida, -
Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
pharmaceutics Review Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice Malavika Deodhar 1, Sweilem B Al Rihani 1 , Meghan J. Arwood 1, Lucy Darakjian 1, Pamela Dow 1 , Jacques Turgeon 1,2 and Veronique Michaud 1,2,* 1 Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, FL 32827, USA; [email protected] (M.D.); [email protected] (S.B.A.R.); [email protected] (M.J.A.); [email protected] (L.D.); [email protected] (P.D.); [email protected] (J.T.) 2 Faculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada * Correspondence: [email protected]; Tel.: +1-856-938-8697 Received: 5 August 2020; Accepted: 31 August 2020; Published: 4 September 2020 Abstract: In an ageing society, polypharmacy has become a major public health and economic issue. Overuse of medications, especially in patients with chronic diseases, carries major health risks. One common consequence of polypharmacy is the increased emergence of adverse drug events, mainly from drug–drug interactions. The majority of currently available drugs are metabolized by CYP450 enzymes. Interactions due to shared CYP450-mediated metabolic pathways for two or more drugs are frequent, especially through reversible or irreversible CYP450 inhibition. The magnitude of these interactions depends on several factors, including varying affinity and concentration of substrates, time delay between the administration of the drugs, and mechanisms of CYP450 inhibition. Various types of CYP450 inhibition (competitive, non-competitive, mechanism-based) have been observed clinically, and interactions of these types require a distinct clinical management strategy. This review focuses on mechanism-based inhibition, which occurs when a substrate forms a reactive intermediate, creating a stable enzyme–intermediate complex that irreversibly reduces enzyme activity. -
Potent Inhibition of Monoamine Oxidase B by a Piloquinone from Marine-Derived Streptomyces Sp. CNQ-027
J. Microbiol. Biotechnol. (2017), 27(4), 785–790 https://doi.org/10.4014/jmb.1612.12025 Research Article Review jmb Potent Inhibition of Monoamine Oxidase B by a Piloquinone from Marine-Derived Streptomyces sp. CNQ-027 Hyun Woo Lee1, Hansol Choi2, Sang-Jip Nam2, William Fenical3, and Hoon Kim1* 1Department of Pharmacy and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea 2Department of Chemistry and Nano Science, Ewha Womans University, Seoul 03760, Republic of Korea 3Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, La Jolla, CA 92093-0204, USA Received: December 19, 2016 Revised: December 27, 2016 Two piloquinone derivatives isolated from Streptomyces sp. CNQ-027 were tested for the Accepted: January 4, 2017 inhibitory activities of two isoforms of monoamine oxidase (MAO), which catalyzes monoamine neurotransmitters. The piloquinone 4,7-dihydroxy-3-methyl-2-(4-methyl-1- oxopentyl)-6H-dibenzo[b,d]pyran-6-one (1) was found to be a highly potent inhibitor of First published online human MAO-B, with an IC50 value of 1.21 µM; in addition, it was found to be highly effective January 9, 2017 against MAO-A, with an IC50 value of 6.47 µM. Compound 1 was selective, but not extremely *Corresponding author so, for MAO-B compared with MAO-A, with a selectivity index value of 5.35. Compound 1,8- Phone: +82-61-750-3751; dihydroxy-2-methyl-3-(4-methyl-1-oxopentyl)-9,10-phenanthrenedione (2) was moderately Fax: +82-61-750-3708; effective for the inhibition of MAO-B (IC = 14.50 µM) but not for MAO-A (IC > 80 µM). -
Evidence of Pyrimethamine and Cycloguanil Analogues As Dual Inhibitors of Trypanosoma Brucei Pteridine Reductase and Dihydrofolate Reductase
pharmaceuticals Article Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase Giusy Tassone 1,† , Giacomo Landi 1,†, Pasquale Linciano 2,† , Valeria Francesconi 3 , Michele Tonelli 3 , Lorenzo Tagliazucchi 2 , Maria Paola Costi 2 , Stefano Mangani 1 and Cecilia Pozzi 1,* 1 Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018–2022, University of Siena, via Aldo Moro 2, 53100 Siena, Italy; [email protected] (G.T.); [email protected] (G.L.); [email protected] (S.M.) 2 Department of Life Science, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy; [email protected] (P.L.); [email protected] (L.T.); [email protected] (M.P.C.) 3 Department of Pharmacy, University of Genoa, Viale Benedetto XV n.3, 16132 Genoa, Italy; [email protected] (V.F.); [email protected] (M.T.) * Correspondence: [email protected]; Tel.: +39-0577-232132 † These authors contributed equally to this work. Abstract: Trypanosoma and Leishmania parasites are the etiological agents of various threatening Citation: Tassone, G.; Landi, G.; neglected tropical diseases (NTDs), including human African trypanosomiasis (HAT), Chagas disease, Linciano, P.; Francesconi, V.; Tonelli, and various types of leishmaniasis. Recently, meaningful progresses in the treatment of HAT, due to M.; Tagliazucchi, L.; Costi, M.P.; Trypanosoma brucei (Tb), have been achieved by the introduction of fexinidazole and the combination Mangani, S.; Pozzi, C. Evidence of therapy eflornithine–nifurtimox. Nevertheless, due to drug resistance issues and the exitance of Pyrimethamine and Cycloguanil animal reservoirs, the development of new NTD treatments is still required. -
Supplementary Table S1 List of Proteins Identified with LC-MS/MS in the Exudates of Ustilaginoidea Virens Mol
Supplementary Table S1 List of proteins identified with LC-MS/MS in the exudates of Ustilaginoidea virens Mol. weight NO a Protein IDs b Protein names c Score d Cov f MS/MS Peptide sequence g [kDa] e Succinate dehydrogenase [ubiquinone] 1 KDB17818.1 6.282 30.486 4.1 TGPMILDALVR iron-sulfur subunit, mitochondrial 2 KDB18023.1 3-ketoacyl-CoA thiolase, peroxisomal 6.2998 43.626 2.1 ALDLAGISR 3 KDB12646.1 ATP phosphoribosyltransferase 25.709 34.047 17.6 AIDTVVQSTAVLVQSR EIALVMDELSR SSTNTDMVDLIASR VGASDILVLDIHNTR 4 KDB11684.1 Bifunctional purine biosynthetic protein ADE1 22.54 86.534 4.5 GLAHITGGGLIENVPR SLLPVLGEIK TVGESLLTPTR 5 KDB16707.1 Proteasomal ubiquitin receptor ADRM1 12.204 42.367 4.3 GSGSGGAGPDATGGDVR 6 KDB15928.1 Cytochrome b2, mitochondrial 34.9 58.379 9.4 EFDPVHPSDTLR GVQTVEDVLR MLTGADVAQHSDAK SGIEVLAETMPVLR 7 KDB12275.1 Aspartate 1-decarboxylase 11.724 112.62 3.6 GLILTLSEIPEASK TAAIAGLGSGNIIGIPVDNAAR 8 KDB15972.1 Glucosidase 2 subunit beta 7.3902 64.984 3.2 IDPLSPQQLLPASGLAPGR AAGLALGALDDRPLDGR AIPIEVLPLAAPDVLAR AVDDHLLPSYR GGGACLLQEK 9 KDB15004.1 Ribose-5-phosphate isomerase 70.089 32.491 32.6 GPAFHAR KLIAVADSR LIAVADSR MTFFPTGSQSK YVGIGSGSTVVHVVDAIASK 10 KDB18474.1 D-arabinitol dehydrogenase 1 19.425 25.025 19.2 ENPEAQFDQLKK ILEDAIHYVR NLNWVDATLLEPASCACHGLEK 11 KDB18473.1 D-arabinitol dehydrogenase 1 11.481 10.294 36.6 FPLIPGHETVGVIAAVGK VAADNSELCNECFYCR 12 KDB15780.1 Cyanovirin-N homolog 85.42 11.188 31.7 QVINLDER TASNVQLQGSQLTAELATLSGEPR GAATAAHEAYK IELELEK KEEGDSTEKPAEETK LGGELTVDER NATDVAQTDLTPTHPIR 13 KDB14501.1 14-3-3 -
Sequence Requirement for Peptide Recognition by Rat Brain P2lras Protein Farnesyltransferase
Proc. Natl. Acad. Sci. USA Vol. 88, pp. 732-736, February 1991 Biochemistry Sequence requirement for peptide recognition by rat brain p2lras protein farnesyltransferase (covalent modification/prenylation/mevalonate/tetrapeptides/enzyme inhibition) YUVAL REISS*, SARAH J. STRADLEYt, LILA M. GIERASCHt, MICHAEL S. BROWN*, AND JOSEPH L. GOLDSTEIN* Departments of *Molecular Genetics and tPharmacology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235 Contributed by Michael S. Brown, October 30, 1990 ABSTRACT We tested 42 tetrapeptides for their ability to a heterodimer (10, 11). The enzyme recognizes sequences as bind to the rat brain p2l' protein farnesyltransferase as short as four amino acids provided that cysteine is at the estimated by their ability to compete with p2lH"- in a farnesyl- fourth position from the COOH terminus. Recognition was transfer assay. Peptides with the highest affinity had the struc- demonstrated by the ability ofthese peptides to compete with ture Cys-Al-A2-X, where positions Al and A2 are occupied by p21Ha-ras in the protein farnesyltransferase assay. In addition, aliphatic amino acids and position X is-occupied by a COOH- the enzyme adhered to an affinity column containing a terminal methionine, serine, or phenylalanine. Charged resi- hexapeptide corresponding to the COOH-terminal sequence dues reduced affinity slightly at the Al position and much more of p2lKi-msB. A similar enzymatic activity was identified by drastically at the A2 and X positions. Effective inhibitors in- Schaber et al. (12) in crude extracts of bovine brain. cluded tetrapeptides corresponding to the COOH termini of all The above findings suggest that the recognition site for the animal cell proteins known to be farnesylated. -
Reproductionresearch
REPRODUCTIONRESEARCH SPINK3 modulates mouse sperm physiology through the reduction of nitric oxide level independently of its trypsin inhibitory activity L Zalazar, T E Saez Lancellotti1, M Clementi1, C Lombardo, L Lamattina, R De Castro, M W Forne´s1 and A Cesari Instituto de Investigaciones Biolo´gicas (IIB), Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Mar del Plata, CCT–Mar del Plata, CONICET, Funes 3250, 4th Floor, Mar del Plata 7600, Argentina and 1Laboratorio de Investigaciones Androlo´gicas de Mendoza (LIAM, IHEM–CONICET), Facultad de Ciencias Me´dicas, Universidad Nacional de Cuyo, CCT–Mendoza, CONICET, Mendoza, Argentina Correspondence should be addressed to A Cesari; Email: [email protected] M W Forne´s and A Cesari contributed equally to this work Abstract Serine protease inhibitor Kazal-type (SPINK3)/P12/PSTI-II is a small secretory protein from mouse seminal vesicle which contains a C KAZAL domain and shows calcium (Ca2 )-transport inhibitory (caltrin) activity. This molecule was obtained as a recombinant protein and its effect on capacitated sperm cells was examined. SPINK3 inhibited trypsin activity in vitro while the fusion protein GST-SPINK3 had no effect on this enzyme activity. The inactive GST-SPINK3 significantly reduced the percentage of spermatozoa positively stained for nitric oxide (NO) with the specific probe DAF-FM DA and NO concentration measured by Griess method in capacitated mouse sperm; C the same effect was observed when sperm were capacitated under low Ca2 concentration, using either intracellular (BAPTA-AM) or C extracellular Ca2 (EDTA) chelators. The percentage of sperm showing spontaneous and progesterone-induced acrosomal reaction was significantly lower in the presence of GST-SPINK3 compared to untreated capacitated spermatozoa. -
Angiotensin-I-Converting Enzyme Inhibitory Activity of Coumarins from Angelica Decursiva
molecules Article Angiotensin-I-Converting Enzyme Inhibitory Activity of Coumarins from Angelica decursiva 1,2,3,4, 1, 5, 1, Md Yousof Ali y, Su Hui Seong y , Hyun Ah Jung * and Jae Sue Choi * 1 Department of Food and Life Science, Pukyong National University, Busan 48513, Korea; [email protected] (M.Y.A.); [email protected] (S.H.S.) 2 Department of Chemistry and Biochemistry, Concordia University, Montreal, QC H4B 1R6, Canada 3 Department of Biology, Faculty of Arts and Science, Concordia University, 7141 Sherbrooke St. W., Montreal, QC H4B 1R6, Canada 4 Centre for Structural and Functional Genomic, Department of Biology, Faculty of Arts and Science, Concordia University, 7141 Sherbrooke St. W., Montreal, QC H4B 1R6, Canada 5 Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju 54896, Korea * Correspondence: [email protected] (H.A.J.); [email protected] (J.S.C.); Tel.: +82-63-270-4882 (H.A.J.); +82-51-629-5845 (J.S.C.) These authors contributed equally to this work. y Academic Editor: Rachid Skouta Received: 11 October 2019; Accepted: 30 October 2019; Published: 31 October 2019 Abstract: The bioactivity of ten traditional Korean Angelica species were screened by angiotensin-converting enzyme (ACE) assay in vitro. Among the crude extracts, the methanol extract of Angelica decursiva whole plants exhibited potent inhibitory effects against ACE. In addition, the ACE inhibitory activity of coumarins 1–5, 8–18 was evaluated, along with two phenolic acids (6, 7) obtained from A. decursiva. Among profound coumarins, 11–18 were determined to manifest marked inhibitory activity against ACE with IC50 values of 4.68–20.04 µM. -
Bacterial Tropone Natural Products and Derivatives
Reviews ChemBioChem doi.org/10.1002/cbic.201900786 1 2 3 Bacterial Tropone Natural Products and Derivatives: 4 5 Overview of their Biosynthesis, Bioactivities, Ecological Role 6 and Biotechnological Potential 7 8 Ying Duan,[a] Melanie Petzold,[a] Raspudin Saleem-Batcha,[a] and Robin Teufel*[a] 9 10 11 Tropone natural products are non-benzene aromatic com- sulfur among other reactions. Tropones play important roles in 12 pounds of significant ecological and pharmaceutical interest. the terrestrial and marine environment where they act as 13 Herein, we highlight current knowledge on bacterial tropones antibiotics, algaecides, or quorum sensing signals, while their 14 and their derivatives such as tropolones, tropodithietic acid, bacterial producers are often involved in symbiotic interactions 15 and roseobacticides. Their unusual biosynthesis depends on a with plants and marine invertebrates (e.g., algae, corals, 16 universal CoA-bound precursor featuring a seven-membered sponges, or mollusks). Because of their potent bioactivities and 17 carbon ring as backbone, which is generated by a side reaction of slowly developing bacterial resistance, tropones and their 18 of the phenylacetic acid catabolic pathway. Enzymes encoded derivatives hold great promise for biomedical or biotechnolog- 19 by separate gene clusters then further modify this key ical applications, for instance as antibiotics in (shell)fish 20 intermediate by oxidation, CoA-release, or incorporation of aquaculture. 21 22 23 1. Introduction pathways and unforeseen enzyme reactions may impair 24 detection and structural predictions.[3] 25 Structurally diverse natural products are typically generated by A remarkable case of such a noncanonical biosynthetic 26 dedicated secondary metabolic pathways that mostly operate route is found for bacterial tropone (9) natural products and 27 in microbes and plants.